We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Premaitha Health Signs Two New Customers

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Premaitha Health PLC has signed two new service contracts with customers in Armenia and Republic of Moldova. These contracts expand Premaitha’s customer base into new international markets, enabling more pregnant women to benefit from the safety and accuracy of NIPT.

Dr Stephen Little, CEO of Premaitha said: “We are pleased to see our international footprint increase as demand for NIPT using the IONA® test grows. The high clinical standards and excellent customer support offered by Premaitha’s screening services team, coupled with the proven performance of the IONA® test means that we are able to provide pregnant women with the best possible screening test.”

Premaitha initiated its Care Quality Commission (CQC) registered NIPT screening service in July 2015 and in October opened a dedicated facility in response to customer demand for the IONA® test. The laboratory provides a routine NIPT screening service for many of its customers as well as an interim solution for those keen to start offering NIPT whilst establishing their own IONA® laboratory in-house.